Here are relevant reports on : gene-editing-technologies-market
-
AI Image Generator Market by Technology (Convolutional Neural Networks, Autoregressive Models, Diffusion Models; Image Generation, Image Captioning, Image Manipulation, Video Generation, Video Synthesis, Video Editing) - Global Forecast to 2030
The AI image generator market is projected to reach USD 60.8 billion in 2030, experiencing a compound annual growth rate (CAGR) of 38.2% during the forecast period. The significant AI image generator market Companies include Google (US), Microsoft (US), AWS (US), Adobe (US), NVIDIA (US), OpenAI (US), Meta (US), Anthropic (US), Databricks (US), Synthesia (UK), VEED.io (England), Runway (US), Jasper (US), Krea AI (US), Simplified (US), Lumen5 (Canada), Lightricks (Israel), Hypotenuse AI (US), Writesonic (US), Colossyan (UK), D-ID (Israel), Midjourney (US), Descript (US), Animaker (US), DeepBrain AI (US), Caspa AI (UK), Facet AI (US), Canva (Australia), Luma AI (US), Kuaishou Technology (China), Fliki (US), Elai.io (US), Speechify (US), Inworld AI (US), Invideo (US), HeyGen (US), Tavus (US), Lovo AI (US), Appy Pie (India), Designs.ai (Singapore), FlexClip (China), and Wondershare (China). These companies have used organic and inorganic growth strategies such as product launches, acquisitions, and partnerships to strengthen their position in the AI image generator market.
- Published: August 2024
- Price: $ 4950
- TOC Available:
-
Video Processing Platform Market by Offering (Video Encoding & Transcoding, Video Management), Content Type (VOD, Short Form Video), Application (Video Ingest & Capture, Video Delivery & Distribution, Video Editing & Enhancement) - Global Forecast to 2030
The video processing platform market is expanding rapidly. The projected market size is expected to rise from USD 7.50 billion in 2025 to USD 12.40 billion by 2030, reflecting a CAGR of 10.6%, during the forecast period. The major players in the video processing platform market include Akamai Technologies (US), MediaKind (US), Harmonic (US), Synamedia (UK), Avid Technology (US), Brightcove (US), and Kaltura (US).
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
Advanced Memory Technologies Market: PCRAM (Phase-Change), RERAM (Resistive), STTRAM (Spin Transfer Torque) By Products, Applications & Technologies - Forecast & Trend Analysis (2012-2017)
PCRAM technology, being non-volatile provides power saving opportunities to the end users. Although it is observed to possess features better than the conventional solutions such as SRAM, flash memory and DRAM, its reach in the mass markets is yet to gain momentum. While Micron Technology (HEADQUARTERS) and Samsung (Korea) lead the R&D activities with respect to PCRAM, there are also a number of other companies and universities such as Shanghai Institute of Microsystem and Information Technology of the Chinese Academy of Sciences, Microchip Technology Inc (HEAD), Semiconductor Manufacturing International Corp (HEAD) and more contribute effectively to its R&D.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Leukapheresis Market by Type (Filter, Membrane Separator, Centrifugal Device), Leukopak (Mobilized, Isolated PBMC), Application (Research [Cell & Gene Therapy, Transplantation], Therapeutic), Indication, End User, Region - Global Forecast to 2031
The global Leukapheresis market, valued at USD 83.3 billion in 2025, stood at USD 90.6 billion in 2026 and is projected to advance at a resilient CAGR of 8.9% from 2026 to 2031, culminating in a forecasted valuation of USD 138.7 billion by the end of the period. This growth is driven by the increasing number of therapeutic and manufacturing applications for leukapheresis in hematologic disorders, as well as the rising demand for high-quality starting materials used in cell and gene therapy, including CAR-T, TCR, and NK-cell programs.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Biologics Safety Testing Market by Product & Service (Consumables, Instrument, Services), Test Type (Mycoplasma, Sterility, Endotoxin, Bioburden, Virus Safety), Application (Vaccines, mAbs, Cell & Gene Therapy, Blood Products) - Global Forecast to 2029
The global biologics safety testing market, valued at US$3.9 billion in 2023, stood at US$4.2 billion in 2024 and is projected to advance at a resilient CAGR of 11.1% from 2024 to 2029, culminating in a forecasted valuation of US$7.2 billion by the end of the period. Growth of the market can be attributed to factors such as the rising need for novel biotherapeutics and increasing focus on advancement of biopharmaceutical industry.
- Published: May 2024
- Price: $ 4950
- TOC Available:
-
Continuous Bioprocessing Market by Product (Chromatography, Filtration, Bioreactor, Media), Process (Upstream, Downstream), Scale of Operation (Commercial, Clinical), Application (mAbs, Vaccines, Cell & Gene Therapy), & End User - Global Forecast to 2028
The global continuous bioprocessing market, valued at US$201 million in 2022, stood at US$218 million in 2023 and is projected to advance at a resilient CAGR of 22.4% from 2023 to 2028, culminating in a forecasted valuation of US$599 million by the end of the period. The growth of the market is largely driven by rising demand for biopharmaceuticals, advantages of continuous bioprocessing over batch/fed-batch mode, and emergence of integrated end-to-end continuous bioprocessing.
- Published: November 2023
- Price: $ 4950
- TOC Available:
-
Viral Vector & Plasmid DNA Manufacturing Market by Type (Viral Vector (Retroviruses, Adenoviruses, AAV, Lentiviruses), Plasmid DNA), Workflow (Upstream, Downstream), Application (Cell & Gene Therapy), Diseases (Cancer), End User - Global Forecast to 2028
The global viral vector manufacturing market, valued at US$4.8 billion in 2022, stood at US$5.5 billion in 2023 and is projected to advance at a resilient CAGR of 18.2% from 2023 to 2028, culminating in a forecasted valuation of US$12.8 billion by the end of the period. The growth of this market is majorly driven by g rising prevalence of target diseases and disorders, the availability of funding for gene therapy development, and effectiveness of viral vectors in gene therapy delivery.
- Published: June 2023
- Price: $ 4950
- TOC Available:
-
Recombinant Proteins Market by Product (Growth Factors, Chemokines, Structural Proteins, Membrane Proteins), Application (Drug Discovery & Development (Biologics, Vaccines, Cell & Gene Therapy), Research, Biopharma Production) & Region - Global Forecast to 2028
The global recombinant proteins market, valued at US$2.1 billion in 2022, stood at US$2.2 billion in 2023 and is projected to advance at a resilient CAGR of 7.2% from 2023 to 2028, culminating in a forecasted valuation of US$3.2 billion by the end of the period. Growth in the market can be attributed to factors such as rising incidence of chronic diseases, growing demand for biologics and biosimilars due to expiration of patents, rising demand for customized medicine and increasing government initiatives for R&D in life sciences research.
- Published: January 2024
- Price: $ 4950
- TOC Available:
-
Bioinformatics Services Market by Type (Sequencing, Data Analysis, Discovery, Gene Expression, Database Management), Specialty (Medical, Plant, Forensics), Application (Genomics, Metabolomics), Enduser (Academia, Pharma-biotech) - Global Forecast to 2026
The global bioinformatics services market growth is primed to transition from $2.5 billion in 2021 to $5.3 billion by 2026, showcasing a strong CAGR of 15.8%. Growing applications of bioinformatics across industries, increasing public-private sector funding for bioinformatics services, and the shortage of skilled bioinformatics professionals (leading to increased outsourcing of bioinformatics projects) are the major factors that are expected to drive the growth of the bioinformatics services market during the forecast period.
- Published: July 2021
- Price: $ 4950
- TOC Available:
-
Regenerative Medicine Market by Product (Stem Cell [Autologous, Allogenic], Immunotherapy, Gene Therapy, Tissue Engineering), Application (Musculoskeletal, Cancer, Dermatology, Wound care, Cardiovascular Diseases, Eye Disorders) & Region - Global Forecast to 2028
The global regenerative medicine market, valued at US$13.5 billion in 2022, stood at US$16.0 billion in 2023 and is projected to advance at a resilient CAGR of 25.1% from 2023 to 2028, culminating in a forecasted valuation of US$49.0 billion by the end of the period. The growth of this market is characterized by the increasing collaborations and partnerships by major market players, and the emerging applications in new therapeutic areas. Rising focus on personalized medicine and increasing regulatory approvals in regenerative medicine are also predicted to drive the market.
- Published: January 2024
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
